Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial - Felip, E; Altorki, N; Zhou, C (Lancet, 2021)
et al.